A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection - Hassanein, Tarek; Sims, Karen D.; Bennett, Michael; Gitlin, Norman; Lawitz, Eric; Nguyen, Tuan; Webster, Lynn; Younossi, Zobair; Schwartz, Howard; Thuluvath, Paul J.; Zhou, Helen; Rege, Bhaskar; et al. (Journal of hepatology, 2015)
Keywords: Adult; Antiviral Agents - administration & dosage; Antiviral Agents - adverse effects; Benzazepines - administration & dosage; Benzazepines - adverse effects; Drug Monitoring; Drug Resistance, Viral; Enzyme Inhibitors - administration & dosage; Enzyme Inhibitors - adverse effects; Female; Gastroenterology and Hepatology; Hepacivirus - drug effects; Hepacivirus - genetics; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - virology; Humans; Imidazoles - administration & dosage; Imidazoles - adverse effects; Indoles - administration & dosage; Indoles - adverse effects; Isoquinolines - administration & dosage; Isoquinolines - adverse effects; Male; Middle Aged; Sulfonamides - administration & dosage; Sulfonamides - adverse effects; Treatment Outcome